Aviceda Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series C

Recent Raise

$207.5M

Aviceda Therapeutics is a biotech company developing next-generation immunomodulators for ophthalmic conditions using its proprietary HALOS™ nanotechnology platform.